This is a StreetInsider.com Premium Only Page

SurModics (SRDX) – Company Press Releases

Apr 19, 2024 07:00 AM Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1

Feb 27, 2024 08:00 AM Surmodics to Participate in Upcoming Investor Conferences in March and April

Feb 1, 2024 07:00 AM Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance

Jan 22, 2024 07:30 AM Surmodics Announces Successful Early Clinical Use of Pounce™ LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the

Jan 16, 2024 07:30 AM Surmodics to Host Virtual Annual Meeting of Shareholders

Jan 16, 2024 07:30 AM Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1

Nov 16, 2023 07:30 AM Surmodics Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH Symposium

Nov 16, 2023 07:30 AM Surmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposium

Nov 14, 2023 04:05 PM Surmodics to Participate in the Piper Sandler Healthcare Conference on November 28

Nov 8, 2023 07:30 AM Surmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial Guidance

Nov 7, 2023 07:30 AM Surmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15

Nov 7, 2023 07:30 AM Surmodics Announces TRANSCEND Trial 36-Month Data to be Presented at 50th Annual VEITH Symposium

Oct 31, 2023 07:30 AM Surmodics Announces Launch of Preside™ Medical Device Coating Technology, Providing Industry-Leading Lubricity and Durability to a Broader Range of Complex Device Applications

Oct 10, 2023 07:30 AM Surmodics to Report Fourth Quarter and Fiscal 2023 Financial Results on November 8

Aug 9, 2023 05:05 PM Surmodics to Participate in Upcoming Investor Conferences in August

Aug 2, 2023 07:31 AM Surmodics Reports Third Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance

Jul 12, 2023 07:30 AM Surmodics to Report Third Quarter of Fiscal 2023 Financial Results on August 2

Jun 27, 2023 07:05 AM KORU Medical Systems, Inc. Names Andrew LaFrence as Chief Financial Officer

Jun 20, 2023 06:30 AM Surmodics Receives FDA Approval for the SurVeil™ Drug-Coated Balloon

Jun 14, 2023 07:30 AM Surmodics Receives FDA 510(k) Clearance for Pounce™ LP Thrombectomy System

May 25, 2023 04:05 PM Surmodics to Participate in the Jefferies Healthcare Conference on June 8

Apr 26, 2023 07:00 AM Surmodics Reports Second Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance

Apr 20, 2023 07:05 AM Surmodics Announces First Patient Enrolled in PROWL Registry Study Using the Pounce™ Thrombectomy System

Apr 19, 2023 07:30 AM Surmodics to Report Second Quarter of Fiscal 2023 Financial Results on April 26

Apr 19, 2023 07:00 AM Surmodics Announces Successful First Patient Use of Sublime™ Radial Access Microcatheter Designed for the Periphery

Apr 11, 2023 08:30 AM Surmodics to Participate in the 22nd Annual Needham Virtual Healthcare Conference on April 20

Mar 28, 2023 09:25 AM Surmodics Provides Regulatory Update on its Strategy to Submit an Amended Premarket Approval Application for the SurVeil™ Drug-Coated Balloon

Mar 9, 2023 07:20 PM ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation – SRDX

Mar 8, 2023 08:30 AM Surmodics to Participate in Upcoming Investor Conferences in March

Mar 3, 2023 06:56 PM Fair Isaac & Co. Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

Mar 3, 2023 01:05 PM SRDX NOTICE: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation – SRDX

Feb 23, 2023 07:40 PM ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation – SRDX

Feb 9, 2023 07:51 PM NATIONALLY RANKED ROSEN LAW FIRM Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation – SRDX

Feb 6, 2023 04:05 PM Surmodics Reports First Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance

Jan 31, 2023 08:30 AM Surmodics to Host Virtual Annual Meeting of Shareholders

Jan 26, 2023 08:30 AM Surmodics to Report First Quarter of Fiscal 2023 Financial Results on February 6

Jan 19, 2023 08:30 AM Differentiated Capabilities of Surmodics’ Crystalline Drug Release Platform for Sirolimus-Coated Balloons Presented at ISET Conference

Jan 19, 2023 07:00 AM Surmodics Provides Regulatory Update Related to its FDA Premarket Approval Application for the SurVeil™ Drug-Coated Balloon

Jan 16, 2023 08:30 AM Surmodics Announces SWING Trial 12-Month Data to be Presented at ISET Conference on January 18

Nov 17, 2022 08:30 AM Surmodics Announces 12-Month Data from the SWING Trial Presented at VEITHsymposium

Nov 11, 2022 08:30 AM Surmodics Announces SWING Trial 12-Month Data to be Presented at VEITHsymposium on November 16

Nov 9, 2022 07:00 AM Surmodics Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Financial Guidance

Nov 2, 2022 08:30 AM 24-Month Data from Surmodics’ TRANSCEND Trial Presented at VIVA 2022 Conference

Oct 28, 2022 07:30 AM Surmodics to Report Fourth Quarter and Fiscal Year 2022 Financial Results on November 9th

Oct 26, 2022 08:30 AM Surmodics Announces TRANSCEND Trial 24-Month Data to be Presented at VIVA 2022

Oct 17, 2022 08:30 AM Surmodics Announces New Credit Facilities Providing up to $125 Million in Financing

Oct 11, 2022 08:30 AM 6-Month Data from the Surmodics SWING BTK First-in-Human Trial Presented at AMP Europe

Oct 7, 2022 08:30 AM 6-Month Data from the Surmodics SWING First-in-Human Study to be Presented at AMP Europe

Aug 23, 2022 08:30 AM Surmodics to Present at Upcoming Gilmartin Emerging Growth Company Showcase Wednesday, August 31, 2022

Jul 27, 2022 07:30 AM Surmodics Reports Third Quarter Fiscal 2022 Results